ProfileGDS4718 / 205151_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 44% 47% 49% 47% 49% 55% 47% 44% 50% 48% 45% 45% 47% 51% 45% 46% 50% 59% 47% 53% 48% 52% 45% 50% 50% 61% 48% 51% 46% 44% 46% 52% 52% 48% 57% 55% 51% 53% 50% 59% 49% 48% 80% 57% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.1956344
GSM549102patient 115, normal, homogenized [OPG study]5.3722147
GSM549104patient 119, normal, homogenized [OPG study]5.4273149
GSM549108patient 138, normal, homogenized [OPG study]5.4166347
GSM549119patient 077, normal, homogenized [OPG study]5.4875349
GSM549133patient 032, cancer, homogenized [OPG study]5.7720255
GSM549139patient 042, cancer, homogenized [OPG study]5.3214947
GSM549099patient 107, normal, homogenized [OPG study]5.2288344
GSM549109patient 139, normal, homogenized [OPG study]5.5095750
GSM549110patient 046, normal, homogenized [OPG study]5.4241348
GSM549114patient 063, normal, homogenized [OPG study]5.1722145
GSM549122patient 082, normal, homogenized [OPG study]5.2537845
GSM549134patient 033, cancer, homogenized [OPG study]5.3432147
GSM549136patient 036, cancer, homogenized [OPG study]5.5082351
GSM549140patient 044, cancer, homogenized [OPG study]5.1775445
GSM549111patient 047, normal, homogenized [OPG study]5.2697446
GSM549113patient 057, normal, homogenized [OPG study]5.4806250
GSM549132patient 031, cancer, homogenized [OPG study]6.0354359
GSM549137patient 038, cancer, homogenized [OPG study]5.3459447
GSM549142patient 047, cancer, homogenized [OPG study]5.7904853
GSM549100patient 110, normal, homogenized [OPG study]5.4253348
GSM549107patient 135, normal, homogenized [OPG study]5.5979752
GSM549115patient 068, normal, homogenized [OPG study]5.1919845
GSM549116patient 072, normal, homogenized [OPG study]5.4758850
GSM549120patient 078, normal, homogenized [OPG study]5.5094650
GSM549131patient 030, cancer, homogenized [OPG study]6.2094561
GSM549118patient 074, normal, homogenized [OPG study]5.4240748
GSM549129patient 027, cancer, homogenized [OPG study]5.613651
GSM549123patient 088, normal, homogenized [OPG study]5.287746
GSM549124patient 006, cancer, homogenized [OPG study]5.2463744
GSM549126patient 015, cancer, homogenized [OPG study]5.2788446
GSM549128patient 025, cancer, homogenized [OPG study]5.6347552
GSM549103patient 117, normal, homogenized [OPG study]5.6810652
GSM549117patient 073, normal, homogenized [OPG study]5.3666148
GSM549138patient 041, cancer, homogenized [OPG study]5.9297757
GSM549141patient 045, cancer, homogenized [OPG study]5.7932955
GSM549130patient 028, cancer, homogenized [OPG study]5.5753351
GSM549101patient 111, normal, homogenized [OPG study]5.7014453
GSM549105patient 128, normal, homogenized [OPG study]5.5204650
GSM549106patient 134, normal, homogenized [OPG study]6.0297759
GSM549112patient 048, normal, homogenized [OPG study]5.4557749
GSM549125patient 011, cancer, homogenized [OPG study]5.4377148
GSM549127patient 024, cancer, homogenized [OPG study]7.9489580
GSM549135patient 035, cancer, homogenized [OPG study]5.9364357